Description

14,70,000 equity shares of Shelter Pharma Limited issued at Rs. 42.25 per share through preferential allotment via warrant conversion, listed for trading from January 22, 2026.

Summary

Shelter Pharma Limited (Scrip Code: 543963) has listed 14,70,000 new equity shares of Rs. 10 face value each, issued at a premium of Rs. 32.25 per share (total issue price Rs. 42.25) to promoters and non-promoters through preferential allotment pursuant to conversion of warrants. These shares will be available for trading on BSE from January 22, 2026, and rank pari-passu with existing equity shares.

Key Points

  • Total new shares listed: 14,70,000 equity shares
  • Face value: Rs. 10 per share
  • Issue price: Rs. 42.25 per share (including premium of Rs. 32.25)
  • Distribution numbers: 14862793 to 16332792
  • Allotment completed in two tranches: 7,35,000 shares each on November 15 and 17, 2025
  • ISIN: INE013V01011
  • Shares rank pari-passu with existing equity shares

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for new securities.

Compliance Requirements

  • Trading members must note the new securities for trading from January 22, 2026
  • Lock-in provisions must be observed as specified below
  • Securities issued through preferential allotment with warrant conversion mechanism

Important Dates

  • Allotment Date (Tranche 1): November 15, 2025 (7,35,000 shares)
  • Allotment Date (Tranche 2): November 17, 2025 (7,35,000 shares)
  • Trading Commencement: January 22, 2026
  • Lock-in Expiry (Partial - 3,36,000 shares): August 14, 2026
  • Lock-in Expiry (Partial - 3,99,000 shares): August 15, 2026
  • Lock-in Expiry (Partial - 2,68,800 shares): August 15, 2026
  • Lock-in Expiry (Final - 4,66,200 shares): August 15, 2027

Impact Assessment

This listing represents a capital raise through preferential allotment with approximately 31.66% of the new shares (4,66,200 shares) subject to extended lock-in until August 2027, while the remaining shares have lock-in periods expiring in August 2026. The staggered lock-in structure indicates a mix of investor categories. The listing increases the freely tradable shares of Shelter Pharma Limited, though immediate liquidity impact is limited due to lock-in restrictions. Market impact is expected to be minimal as this is a routine corporate action affecting a single company with modest issuance size.

Impact Justification

Routine listing of preferential allotment shares with lock-in provisions, minimal market impact for a single company